Anti-abortion groups plan to unveil a sprawling federal and state strategy today that would undermine the procedure’s protections enacted by ballot measure in nearly a dozen states over the past two ...
The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...
This is Part 5 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. When patents for name brand medicines expire, the price of that ...